Evidence map›Paper›PMID 32038762›Full record

ReviewThe Journal of clinical and aesthetic dermatology2019

New and Emerging Topical Therapies for Psoriasis and Atopic Dermatitis.

Corinna E Psomadakis, George Han

Abstract readReview
In one paragraph

Review in The Journal of clinical and aesthetic dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Parameter-based transfer learning for severity classification of atopic dermatitis using hyperspectral imaging.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Air pollution and skin disorders.International journal of women's dermatology · 2021
    Review
  16. Review
  17. Article
  18. Article
  19. Effect of herbal cream containingAvicenna journal of phytomedicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Corinna E PsomadakisDrs. Psomadakis and Han are with the Department of Dermatology, Mount Sinai Medical Center in New York, New York.
George HanDrs. Psomadakis and Han are with the Department of Dermatology, Mount Sinai Medical Center in New York, New York.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psoriasis and atopic dermatitis represent two of the most common skin conditions seen by both primary care and specialist dermatology. The prevalence of psoriasis in North America is 2 to 4 percent, and it is estimated to cost more than $3 billion per year to treat this condition. Atopic dermatitis has an estimated 15 to 30 percent lifetime prevalence in children and an 8 to 10 percent lifetime prevalence in adults. Both diseases have a significant impact on patient quality of life, as well as associated psychological, social, and economic consequences. While systemic therapies are available for both, the majority of patients with each condition are treated with topical therapies alone, with varying degrees of efficacy and patient satisfaction. As such, there is both need and an incentive to develop new treatments for these two conditions. In this paper, we review new and emerging topical therapies for psoriasis and atopic dermatitis.

Indexed as

atopic dermatitisBenvitimodCrisaboroleeczemaenstilarEucrisaGATA-3Genadorhydroxypropyl-chitosanJAK inhibitorJAKSTATPDE4 inhibitorPefcalcitolPH-10phosphodiesterase-4 inhibitorPsoriasisretinoidssernivosteroidtazaroteneTofacitinibtopicalvitamin D analog

Identifiers

PMID32038762
PMCPMC7002051

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.